BioNTech has launched global clinical trials for BNT116, an mRNA vaccine designed to treat non-small cell lung cancer.

The Biden administration has relaunched its program sending free COVID-19 tests in the mail.{beacon} Health Care Health Care ...

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

The University of Dundee and NHS Tayside is the first hospital site in Europe to open a trial of a new investigational ...

Along with the annual flu vaccine, the new COVID-19 vaccine formulation is now widely available in Minnesota. It comes at a ...

Free rapid tests for COVID-19 are now available to order online.As of Friday, Sept. 27, every American household may order ...

The Covid booster jab autumn scheme is opening in just a few days with some Brits eligible and encouraged to get their ...

A federal judge has dismissed a lawsuit by a New York family who claimed the Department of Defense misled Americans into ...

We provide a rundown of Managing IP’s news and analysis from the week, and review what’s been happening elsewhere in IP ...

Barron’s 2024 Healthcare Roundtable panelists make the case for 21 healthcare companies of all stripes, including Humana, ...

Agios Pharmaceuticals (AGIO) stock was downgraded at Leerink Partners on Pfizer's (PFE) recent decision to withdraw sickle ...